Top 20 employers in global biotech and pharma sectors revealed
2024 top biotech and pharma employers survey by Science magazine identifies leading companies in the industry
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Vertex Pharmaceuticals
Vertex could solidify dominance in cystic fibrosis market with vanza triple approval: GlobalData
Vertex’s portfolio of cystic fibrosis transmembrane conductance, regulator modulators, including Kalydeco, Orkambi,…
US FDA gives record number of review designations to CRISPR drugs in 2023: GlobalData
Casgevy is the first CRISPR-based drug to receive marketing authorisation globally
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData
The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023…
Vertex and Arbor Biotechnologies partner to develop novel ex-vivo engineered cell therapies
Vertex to use Arbor’s CRISPR gene-editing technology to enhance efforts in developing novel cell therapies for the treatment of…
Double digit MCap growth in 2019 for 14 of top 20 pharma companies: GlobalData
Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100 per cent YoY growth in…
37 M&A deals worth $18.9 bn in Aug 2019: GlobalData Report
Amgen’s proposed acquisition of Otezla from Celgene for $13.4 billion provides 71 per cent to deal value